Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Οι συνταγές μου Αποθηκεύστε τις συνταγές σας και μοιραστείτε τις εύκολα και με ασφάλεια
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

RECREOL Cream (2017)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

RECREOL 50 mg/g cream.

Qualitative and quantitative composition

1 g cream contains 50 mg of dexpanthenol (Dexpanthenolum). Excipient(s) with known effect: 15 mg propylene glycol, 13 mg wool fat, 24 mg cetyl alcohol and 16 mg stearyl alcohol. For the full list of excipients, ...

Pharmaceutical form

Cream. Homogenous white or yellowish cream with specific odour.

Therapeutic indications

Supportive treatment of superficial skin lesion (such as small burns and lacerations, skin abrasions and cracking), skin inflammation (resulting from exposure of radiation therapy, phototherapy or ultraviolet ...

Posology and method of administration

Posology Dexpanthenol should be applied topically one to several times a day. Paediatric population Dexpanthenol can be used in pediatric population. Patients with renal and hepatic impairment No studies ...

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1; Dexpanthenol is contraindicated on wounds in patients with haemophilia because of risk of severe bleeding. ...

Special warnings and precautions for use

Accidental contact of dexpanthenol with the eyes should be avoided. Dexpanthenol should be discontinued if signs of hypersensitivity occur during use. Patients should be instructed to consult a doctor ...

Interaction with other medicinal products and other forms of interaction

Interaction studies have not been performed with dexpanthenol. There are no known interactions. There is no evidence that topical dexpanthenol interacts with any medicine.

Fertility, pregnancy and lactation

Pregnancy The possible effect of dexpanthenol on reproduction was not studied. There is no data on the use of dexpanthenol in pregnant women. Animal studies do not indicate direct or indirect harmful effects ...

Effects on ability to drive and use machines

Dexpanthenol has no effects on ability to drive and use machines.

Undesirable effects

Adverse reactions are ranked according to system organ class, using the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), ...

Overdose

No data concerning overdose in humans are available. Even in case of unconventional use of excessive dexpanthenol amounts it has low systemic toxicity and causes no undesirable effects that would be dangerous ...

Pharmacodynamic properties

Pharmacotherapeutic group: preparations for treatment of wounds and ulcers, other cicatrizants ATC code: D03AX03 Dexpanthenol is converted in tissues to pantothenic acid, a component of coenzyme A (CoA) ...

Pharmacokinetic properties

Absorption Dexpanthenol rapidly absorbed into the skin, is immediately converted to pantothenic acid, which is widely distributed into body tissues, mainly as coenzyme A. Distribution After topical applications ...

Preclinical safety data

Single-dose toxicity In animals, young rats fed 50mg=day as calcium pantothenate for 190 days had no adverse effects. When bred, their offspring were maintained using the same diets with no signs of abnormal ...

List of excipients

DL-pantolactone Phenoxyethanol Potassium cetyl phosphate Wool fat Propylene glycol Stearyl alcohol Cetyl alcohol Isopropyl myristate Purified water

Incompatibilities

There is no information regarding possible incompatibilities.

Shelf life

Shelf life: 2 years.

Special precautions for storage

This medicinal product does not require any special storage conditions. Do not freeze.

Nature and contents of container

30 g or 50 g of cream in aluminium tube, interior lacquered with epoxy phenolic coating, and with sealing compound in the fold. Tube is closed with an aluminium membrane and fitted with a white HDPE screw ...

Special precautions for disposal and other handling

No special requirements for disposal.

Marketing authorization holder

AS GRINDEKS., Krustpils iela 53, Rīga, LV-1057, Latvia, Tel.: +371 67083205, Fax: +371 67083505, E-mail: grindeks@grindeks.lv

Date of revision of the text

02/2017

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.